Bollard Catherine 4
4 · Cabaletta Bio, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Bollard Catherine
Director
Transactions
- Award
Stock Option (Right to buy)
2022-06-01+22,000→ 22,000 totalExercise: $1.28Exp: 2032-05-31→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full upon the earlier of (1) June 1, 2023 or (2) the date of the next annual meeting of the Corporation's stockholders.